Adaptimmune Ther Ads (ADAP)

$5.72 0.38 (6.23%)

19:32 EST ADAP Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 538.50M

PE Ratio -7.94

EPS -0.72

Volume (Avg. Vol.) 1.60M

Day's Range 5.65 - 6.20

52-Week Range 2.00 - 13.40

Dividend & Yield N/A (N/A)

ADAP Stock Predictions, Articles, and Adaptimmune Ther Ads News

From InvestorPlace
From the Web

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Sep 22, 2020

The pandemic has raised awareness about the value of biotech across the world. In turn, these biotech stocks will benefit down the road.

Interesting ADAP Put And Call Options For September 17th

From Market News Video Jan 15, 2021

Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options begin trading this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

First Week of ADAP February 19th Options Trading

From Market News Video Jan 11, 2021

Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the February 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADAP options chain for the new February 19th contracts and identified one put and one call contract of particular interest.

Adaptimmune Therapeutics Enters Oversold Territory (ADAP)

From Market News Video Nov 24, 2020

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

A Buy the Dip Stock Trigger in Adaptimmune Therapeutics PLC

From Capital Market Laboratories Oct 22, 2020

The Techncial Trigger Driven Stock Trade in Adaptimmune Therapeutics PLC (NASDAQ:ADAP) .

Notable Two Hundred Day Moving Average Cross - ADAP

From Market News Video Oct 16, 2020

In trading on Friday, shares of Adaptimmune Therapeutics PLC (ADAP) crossed below their 200 day moving average of $6.26, changing hands as low as $6.25 per share. Adaptimmune Therapeutics PLC shares are currently trading off about 20.1% on the day..

2 Cancer Stocks That Could Make You Filthy Rich

From The Motley Fool Nov 8, 2020

Adaptimmune Therapeutics and Trillium Therapeutics could be big winners for early shareholders.

Navellier Ratings

Total Grade

Buy